Cargando…
Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels
BACKGROUND: The transcription factor hypoxia inducible factor (HIF) -1 drives tumor growth and metastasis and is associated with poor prognosis in breast cancer. Ascorbate can moderate HIF-1 activity in vitro and is associated with HIF pathway activation in a number of cancer types, but whether tiss...
Autores principales: | Campbell, Elizabeth J., Dachs, Gabi U., Morrin, Helen R., Davey, Valerie C., Robinson, Bridget A., Vissers, Margreet C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448303/ https://www.ncbi.nlm.nih.gov/pubmed/30943919 http://dx.doi.org/10.1186/s12885-019-5503-x |
Ejemplares similares
-
The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein
por: Wohlrab, Christina, et al.
Publicado: (2018) -
Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal Cancer
por: Kuiper, Caroline, et al.
Publicado: (2014) -
Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(−/−) mice
por: Campbell, Elizabeth J, et al.
Publicado: (2015) -
Gulonolactone Addition to Human Hepatocellular Carcinoma Cells with Gene Transfer of Gulonolactone Oxidase Restores Ascorbate Biosynthesis and Reduces Hypoxia Inducible Factor 1
por: Flett, Teresa, et al.
Publicado: (2014) -
Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo(−/−) mice
por: Campbell, Elizabeth J, et al.
Publicado: (2016)